Cyclic AMP Suppression Is Sufficient to Induce Gliomagenesis in a Mouse Model of Neurofibromatosis-1
Open Access
- 14 July 2010
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 70 (14), 5717-5727
- https://doi.org/10.1158/0008-5472.can-09-3769
Abstract
Current models of oncogenesis incorporate the contributions of chronic inflammation and aging to the patterns of tumor formation. These oncogenic pathways, involving leukocytes and fibroblasts, are not readily applicable to brain tumors (glioma), and other mechanisms must account for microenvironmental influences on central nervous system tumorigenesis. Previous studies from our laboratories have used neurofibromatosis-1 (NF1) genetically engineered mouse (GEM) models to understand the spatial restriction of glioma formation to the optic pathway of young children. Based on our initial findings, we hypothesize that brain region–specific differences in cAMP levels account for the pattern of NF1 gliomagenesis. To provide evidence that low levels of cAMP promote glioma formation in NF1, we generated foci of decreased cAMP in brain regions where gliomas rarely form in children with NF1. Focal cAMP reduction was achieved by forced expression of phosphodiesterase 4A1 (PDE4A1) in the cortex of Nf1 GEM strains. Ectopic PDE4A1 expression produced hypercellular lesions with features of human NF1-associated glioma. Conversely, pharmacologic elevation of cAMP with the PDE4 inhibitor rolipram dramatically inhibited optic glioma growth and tumor size in Nf1 GEM in vivo. Together, these results indicate that low levels of cAMP in a susceptible Nf1 mouse strain are sufficient to promote gliomagenesis, and justify the implementation of cAMP-based stroma-targeted therapies for glioma. Cancer Res; 70(14); 5717–27. ©2010 AACR.Keywords
Other Versions
This publication has 38 references indexed in Scilit:
- Stimulatory heterotrimeric G protein augments gamma ray-induced apoptosis by up-regulation of Bak expression via CREB and AP-1 in H1299 human lung cancer cellsExperimental & Molecular Medicine, 2009
- Shared oligodendrocyte lineage gene expression in gliomas and oligodendrocyte progenitor cellsJournal of Neurosurgery, 2003
- Microglia in brain tumorsGlia, 2002
- Astrocyte-Specific Inactivation of the Neurofibromatosis 1 Gene (NF1) Is Insufficient for Astrocytoma FormationMolecular and Cellular Biology, 2002
- Neurofibromas in NF1: Schwann Cell Origin and Role of Tumor EnvironmentScience, 2002
- Epidermal growth factor receptor and Ink4a/Arf: Convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axisCancer Cell, 2002
- Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral VectorsScience, 2002
- Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): A retrospective study of 104 patientsBrain, 2002
- Loss ofNF1Alleles Distinguish Sporadic from NF1-Associated Pilocytic AstrocytomasJournal of Neuropathology and Experimental Neurology, 2001
- Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomasProceedings of the National Academy of Sciences of the United States of America, 2000